Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve PILOCARPINE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 25
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 25
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 25
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

AUSTARPHARMA

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 23
  • 0 comments

FDA approve FENOFIBRATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 24
  • 0 comments

FDA approve FENOFIBRATE

Comment Full text

SUN PHARM INDS LTD

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve DESMOPRESSIN ACETATE

Comment Full text

AKORN

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve IDARUBICIN HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • March 29, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve LOPERAMIDE HYDROCHLORIDE

Comment Full text
  • Previous
  • 849
  • 850
  • 851
  • 852
  • 853
  • Next

Search

News categories

  • Technical Exchange News(12156)
  • Event(5779)
  • SEC News(257824)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152392)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin